Defining the Intensity of Conditioning Regimens: Working Definitions

Vriesendorp, 2003, Aims of the conditioning regimen, Exp Hematol, 31, 844, 10.1016/S0301-472X(03)00229-7

Grunebaum, 2006, Bone marrow transplantation for severe combined immune deficiency, JAMA, 295, 508, 10.1001/jama.295.5.508

Thomas, 1977, One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation, Blood, 49, 511, 10.1182/blood.V49.4.511.511

Santos, 1983, Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide, N Engl J Med, 309, 1347, 10.1056/NEJM198312013092202

Hobbs, 1981, Reversal of clinical features of hurler's disease and biochemical improvement after treatment by bone marrow transplantation, Lancet, 3, 709, 10.1016/S0140-6736(81)91046-1

Kahl, 1987, Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen, Blood, 70, 1382, 10.1182/blood.V70.5.1382.1382

Lucarelli, 1985, Marrow transplantation for thalassemia after treatment with busulfan and cyclophosphamide, Ann N Y Acad Sci, 445, 428, 10.1111/j.1749-6632.1985.tb17212.x

Clift, 1998, Long-term follow-Up of a randomized trial of 2 irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia, Blood, 92, 1455, 10.1182/blood.V92.4.1455

Marks, 2006, A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission, Biol Blood Marrow Transplant, 12, 438, 10.1016/j.bbmt.2005.12.029

Terenzi, 1996, Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: preliminary results, Transplant Proc, 28, 3101

Aversa, 1998, Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype, N Engl J Med, 339, 1186, 10.1056/NEJM199810223391702

Giralt, 1997, Engraftment of allogeneic hematopoietic progenitor cells with purine analog containing chemotherapy: harnessing graft-versus-leukemia without myelablative therapy, Blood, 89, 4531, 10.1182/blood.V89.12.4531

Giralt, 2001, Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation, Blood, 97, 631, 10.1182/blood.V97.3.631

Slavin, 1998, Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases, Blood, 91, 756, 10.1182/blood.V91.3.756

Corradini, 2005, Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies, J Clin Oncol, 23, 6690, 10.1200/JCO.2005.07.070

Kottaridis, 2000, A non-myeloablative regimen for allogeneic stem cell transplantation with a low incidence of GVHD, Bone Marrow Transplant, 25, S26

Storb, 2001, Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia?, Leukemia, 15, 662, 10.1038/sj.leu.2402034

Bacigalupo, 2004, Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus, Bone Marrow Transplant, 33, 691, 10.1038/sj.bmt.1704416

Gratwohl, 2002, European Group for Blood and Marrow Transplantation (EBMT). Accreditation Committee. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey, Bone Marrow Transplant, 30, 813, 10.1038/sj.bmt.1703819

Giralt, 2009, Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research, Biol Blood Marrow Transplant, 15, 367, 10.1016/j.bbmt.2008.12.497

Lorenz, 1952, Modification of acute irradiation injury in mice and guinea-pigs by bone marrow injections, Radiology, 58, 863, 10.1148/58.6.863

Vos, 1956, Evidence for the cellular hypothesis in radiation protection by bone marrow cells, Acta Physiol Pharmacol Neerl, 4, 482

Thomas, 1957, Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy, N Engl J Med, 257, 491, 10.1056/NEJM195709122571102

Helenglass, 1988, Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission, Bone Marrow Transplant, 3, 21

Jamieson, 2003, Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience, Exp Hematol, 10, 981, 10.1016/S0301-472X(03)00231-5

Kanfer, 1987, Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation, Bone Marrow Transplant, 1, 339

Bacigalupo, 2004, Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation, Haematologica, 89, 1238

Pagel, 2002, The use of radioimmunoconjugates in stem cell transplantation, Bone Marrow Transplant, 29, 807, 10.1038/sj.bmt.1703524

Fox, 1973, Radiation damage and repair phenomena, Br Med Bull, 29, 16, 10.1093/oxfordjournals.bmb.a070949

Brown, 1990, High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy, Blood, 76, 473, 10.1182/blood.V76.3.473.473

Jammet, 1959, Etude de six cas d'irradiation totale aigue accidentelle, Rev Franc Etudes Clin Biol, 4, 210

Khouri, 1998, Transplant lite: induction of graft versus malignancy using fludarabine based non ablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignances, J Clin Oncol, 16, 2817, 10.1200/JCO.1998.16.8.2817

Ballen, 2004, Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy—an updated review, Leuk Lymphoma, 45, 905, 10.1080/10428190310001628167

Lowsky, 2005, Protective conditioning for acute graft-versus-host disease, N Engl J Med, 353, 1321, 10.1056/NEJMoa050642

Sorror, 2004, Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities, Blood, 104, 961, 10.1182/blood-2004-02-0545

Mielcarek, 2003, Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation, Blood, 102, 756, 10.1182/blood-2002-08-2628

Hegenbart, 2006, Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors, J Clin Oncol, 24, 444, 10.1200/JCO.2005.03.1765

Maloney, 2003, Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma, Blood, 102, 3447, 10.1182/blood-2002-09-2955

Childs, 1999, Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect, J Clin Oncol, 17, 10.1200/JCO.1999.17.7.2044

Tauro, 2005, Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia, J Clin Oncol, 23, 9387, 10.1200/JCO.2005.02.0057

Schmid, 2006, Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation, Blood, 108, 1092, 10.1182/blood-2005-10-4165

Aoudjhane, 2005, Leukemia, 19, 2304, 10.1038/sj.leu.2403967

Crawley, 2005, Chromic Leukaemia Working Party of the EBMT. Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT, Blood, 105, 4532, 10.1182/blood-2004-06-2387

Robinson, 2002, Blood, 100, 4310, 10.1182/blood-2001-11-0107

Martino, 2006, Blood, 108, 836, 10.1182/blood-2005-11-4503

Crawley, 2005, Chronic Leukemia Working Party of the EBMT. Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EEBMT, Blood, 106, 2969, 10.1182/blood-2004-09-3544

Storb, 2005, Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up, Br J Haematol, 130, 747

Mapara, 2001, Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance, Biol Blood Marrow Transplant, 7, 646, 10.1053/bbmt.2001.v7.pm11787527

Brodsky, 2004, High dose cyclophosdphamide as salvage therapy for severe aplastic anemia, Exp Hematol, 125, 408

Tisdale, 2000, High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial, Lancet, 356, 1554, 10.1016/S0140-6736(00)03126-3